CommercialDocumentationLow impact
Dr. Beecroft: Using measurement-based care in depression, anxiety and suicide risk to improve outcomes
BCBS Michigan·MI · Psychiatry, Family Medicine, Internal Medicine +3 more·Provider News
We identified it
Jun 26, 2026
Summary
Blue Cross Blue Shield of Michigan is issuing clinical guidance on implementing measurement-based care (MBC) for depression, anxiety, and suicide risk assessment using validated screening instruments (PHQ-9, GAD-7, etc.). This is an informational/educational policy from Dr. Beecroft emphasizing best practices for routine symptom monitoring and the DSF-E HEDIS measure requirements for depression screening and follow-up within 30 days. No specific billing code changes, coverage denials, or prior authorization requirements are introduced.
Action Required
No immediate billing action required. This is a clinical guidance document, not a billing policy change. However, providers and clinical staff should be aware that: (1) The DSF-E HEDIS measure tracks depression screening compliance and 30-day follow-up using EHR data; (2) Accepted screening instruments include PHQ-9, PHQ-2, GAD-7, BDI-FS, PROMIS, CESD-R, EPDS, GDS, CUDOS, and DUKE-AD with specified positive thresholds; (3) Follow-up care within 30 days of a positive screen can include outpatient/telehealth visits, behavioral health encounters, antidepressant medication dispensing, or negative follow-up screening. Billing teams should monitor for any future BCBSM policy updates that may tie MBC documentation requirements to claim submission or reimbursement.